XTX Topco’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Buy |
37,220
+5,440
| +17% | +$198K | 0.06% | 505 |
|
|
2025
Q1 | $1.15M | Buy |
31,780
+20,532
| +183% | +$743K | 0.06% | 484 |
|
|
2024
Q4 | $473K | Sell |
11,248
-3,381
| -23% | -$142K | 0.04% | 799 |
|
|
2024
Q3 | $813K | Buy |
14,629
+7,134
| +95% | +$396K | 0.06% | 522 |
|
|
2024
Q2 | $308K | Sell |
7,495
-5,726
| -43% | -$235K | 0.03% | 941 |
|
|
2024
Q1 | $617K | Buy |
13,221
+5,815
| +79% | +$272K | 0.08% | 363 |
|
|
2023
Q4 | $354K | Sell |
7,406
-5,613
| -43% | -$268K | 0.08% | 495 |
|
|
2023
Q3 | $464K | Buy |
13,019
+3,670
| +39% | +$131K | 0.08% | 449 |
|
|
2023
Q2 | $431K | Sell |
9,349
-1,820
| -16% | -$84K | 0.08% | 468 |
|
|
2023
Q1 | $448K | Buy |
11,169
+5,876
| +111% | +$236K | 0.09% | 364 |
|
|
2022
Q4 | $245K | Buy |
+5,293
| New | +$245K | 0.05% | 713 |
|